<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04953754</url>
  </required_header>
  <id_info>
    <org_study_id>WRNMMC-2021-0353</org_study_id>
    <nct_id>NCT04953754</nct_id>
  </id_info>
  <brief_title>Melatonin and Vaccine Response, Immunity, and Chronobiology Study</brief_title>
  <acronym>MAVRICS</acronym>
  <official_title>Melatonin and Vaccine Response, Immunity, and Chronobiology Study (MAVRICS): The Impact of Sleep, Circadian Health, and Melatonin on Vaccine Immunogenicity and Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Walter Reed National Military Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Walter Reed National Military Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the impact of sleep, circadian health and melatonin on flu vaccine&#xD;
      immunogenicity.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vaccination is critical to public health and disease prevention. However, despite the many&#xD;
      scientific advancements and vaccines on the market, they are not always fully effective.&#xD;
      Adjuvants are often used to boost immunity, but they are associated with more side effects,&#xD;
      possible allergic reactions and public mistrust that supports vaccine hesitancy. Many factors&#xD;
      affect vaccine efficacy and host immunity. Sleep, circadian health and melatonin have been&#xD;
      studied in the past to affect immune response to vaccines and infection. Patient education&#xD;
      about better sleep habits and/or melatonin use are potentially safe, cost effective, and&#xD;
      accessible interventions that may improve host immunity and vaccine effectiveness. However,&#xD;
      neither have been studied rigorously and at this time, are not actively implemented in the&#xD;
      clinical arena. Hence, we propose a study comparing vaccine immunogenicity based on sleep&#xD;
      quality, chronotype, and exogenous melatonin.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective open label melatonin compared to control</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anti-influenza antibody titers</measure>
    <time_frame>14-21 days post vaccination</time_frame>
    <description>Seroconversion and titer &gt;=1:40 post-vaccination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cell-mediated immunity</measure>
    <time_frame>14-21 days post vaccination</time_frame>
    <description>ELISpot (secretion of Interferon-gamma and Granzyme B with restimulation by influenza viral antigens), Flow cytometry to determine CD4+ and CD8+ T cell producing IFN(g) with influenza viral restimulation, and Luminex multiplex cytokine analysis in cell culture supernatant of PBMC after restimulation with influenza viral antigens.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sleep survey - Pittsburgh Sleep Quality Index (PSQI)</measure>
    <time_frame>14-21 days post vaccination</time_frame>
    <description>PSQI and vaccine immunogenicity (primary outcomes)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Actigraph data</measure>
    <time_frame>14-21 days post vaccination</time_frame>
    <description>Correlation of actigraph data and vaccine immunogenicity (primary outcomes)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronotype survey - Munich ChronoType Questionaire (MCTQ)</measure>
    <time_frame>14-21 days post vaccination</time_frame>
    <description>Correlation of MCTQ score with vaccine immunity</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Vaccine Response</condition>
  <condition>Sleep</condition>
  <condition>Circadian Rhythm Disorders</condition>
  <arm_group>
    <arm_group_label>Melatonin Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will get melatonin 5mg nightly</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will not get any treatment (melatonin)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Melatonin</intervention_name>
    <description>The melatonin group will receive 5mg melatonin nightly</description>
    <arm_group_label>Melatonin Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Phillips Actiwatch Spectrum Plus</intervention_name>
    <description>Both groups will be monitored by the FDA-cleared Actigraph</description>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_label>Melatonin Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-64&#xD;
&#xD;
          -  Eligible to receive flu vaccination (at military hospital, DEERS eligible)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergy or contraindication to getting flu vaccine&#xD;
&#xD;
          -  Pregnancy or likelihood of getting pregnant in next few weeks&#xD;
&#xD;
          -  Medical history of doctor diagnosed immune-compromising condition (HIV/AIDS, cancer,&#xD;
             diabetes, significant cardiovascular disease) or doctor diagnosed sleep disorder&#xD;
             (insomnia, narcolepsy).*Sleep apnea is an exclusion unless stable on treatment with&#xD;
             cpap or oral device for more than3 months.&#xD;
&#xD;
          -  Currently taking (or recently, in past 3 months) any immune suppressants or&#xD;
             immunomodulating treatments (systemic corticosteroids, chemotherapy, etc) or sleep&#xD;
             medication or supplement (including over the counter medications and melatonin)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 4, 2021</study_first_submitted>
  <study_first_submitted_qc>June 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 8, 2021</study_first_posted>
  <last_update_submitted>June 29, 2021</last_update_submitted>
  <last_update_submitted_qc>June 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Walter Reed National Military Medical Center</investigator_affiliation>
    <investigator_full_name>Rachel Lee</investigator_full_name>
    <investigator_title>Service Chief, Allergy, Immunology &amp; Immunizations</investigator_title>
  </responsible_party>
  <keyword>Sleep</keyword>
  <keyword>Circadian health</keyword>
  <keyword>Vaccine immunogenicity</keyword>
  <keyword>Melatonin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronobiology Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melatonin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

